基于表观扩散系数构建并验证子宫内膜癌患者术前Ki-67表达预测模型
本研究回顾性分析2017年1月至2023年2月在本院行术前MRI扩散加权成像的280例子宫内膜癌患者,随机分为训练集186例和验证集84例。利用ADCmax联合FIGO分期和化疗构建列线图预测Ki-67表达,训练集AUC为0.783、验证集AUC为0.820,校准曲线和决策曲线提示模型预测效能较好。
要点
- ADCmax联合FIGO分期和化疗构建的列线图可无创预测子宫内膜癌术前Ki-67表达。
- 训练集列线图AUC为0.783,验证集AUC为0.820,校准曲线和决策曲线提示预测效能较好。
- ADCmin和ADCmean与Ki-67表达呈非线性相关(非线性P=0.019)。
核心结论
- 基于ADCmax值联合临床数据构建的列线图预测模型可作为术前无创评估子宫内膜癌患者Ki-67表达的有效方法。
研究设计与样本
- 回顾性分析2017年1月至2023年2月在本院行术前MRI扩散加权成像的280例子宫内膜癌患者。
- 纳入患者随机分为训练集186例和验证集84例。
- 结合逻辑回归和LASSO回归结果筛选出4个最佳预测因子构建列线图。
- 采用受试者工作特征曲线、校准曲线和决策曲线分析评估列线图的准确性和临床适用性。
诊断标准与关键数值
- ADCmin与Ki-67表达呈非线性相关(非线性P=0.019),ADCmean与Ki-67表达呈非线性相关(非线性P=0.019)。
- 列线图纳入ADCmax、FIGO分期和化疗构建。
- 训练集ROC的AUC:列线图0.783、ADCmax 0.718、FIGO 0.579、化疗0.636、分级0.654。
- 验证集AUC:列线图0.820、ADCmax 0.746、FIGO 0.558、化疗0.542、分级0.738。
- 校准曲线和决策曲线提示模型预测效能较好。
临床应用与阅片要点
- 作者认为基于ADCmax联合临床数据的列线图可作为术前无创评估子宫内膜癌Ki-67表达的有效方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: Ki-67 is a marker of cell proliferation and is increasingly being used as a primary outcome measure in preoperative window studies of endometrial cancer (EC). This study explored the feasibility of using apparent diffusion coefficient (ADC) values in noninvasive prediction of Ki-67 expression levels in EC patients before surgery, and constructs a nomogram by combining clinical data.
MATERIAL AND METHODS: This study retrospectively analyzed 280 EC patients who underwent preoperative magnetic resonance imaging (MRI) diffusion-weighted imaging (DWI) in our hospital from January 2017 to February 2023. Evaluate the potential nonlinear relationship between ADC values and Ki-67 expression using the nomogram. The included patients were randomized into a training set (n = 186) and a validation set (n = 84). Using a combination of logistic regression and LASSO regression results, from which the four best predictors were identified for the construction of the nomogram. The accuracy and clinical applicability of the nomogram were assessed using the receiver operating characteristic curve (ROC), calibration curve, and decision curve analysis (DCA).
RESULTS: The results of this study showed a nonlinear correlation between ADCmin and Ki-67 expression (nonlinear P = 0.019), and the nonlinear correlation between ADCmean and Ki-67 expression (nonlinear P = 0.019). In addition, this study constructed the nomogram by incorporating ADCmax, International Federation of Gynecology and Obstetrics (FIGO), and chemotherapy. The area under the curve (AUC) values of the ROC for nomogram, ADCmax, FIGO, chemotherapy and grade in the training set were 0.783, 0.718, 0.579, 0.636, and 0.654, respectively. In the validation set, the AUC values for nomogram, ADCmax, FIGO, chemotherapy, and grade were 0.820, 0.746, 0.558, 0.542, and 0.738, respectively. In addition, the calibration curves and the DCA curves suggested a better predictive efficacy of the model.
CONCLUSION: A nomogram prediction model constructed on the basis of ADCmax values combined with clinical data can be used as an effective method to noninvasively assess Ki-67 expression in EC patients before surgery.
引用
- Zhang M, Jing M, Li R, et al. Construction and validation of a prediction model for preoperative prediction of Ki-67 expression in endometrial cancer patients by apparent diffusion coefficient. Clin Radiol. 2024. PMID: 39129106. doi:10.1016/j.crad.2024.05.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。